References
- Haas H., Hartfelder G. α-Isopropyl-α-[(N-methyl-N-homoveratryl)- γ-aminopropyl] -3–4dimethoxyphenyl-acetonitril, eine substance mit coronargefaberweiternden Eigenshaften. Arzneim-Forsch. 1962; 12: 549
- Brichard G., Zimmermann P. E. Verapamil in cardiac dysrhythymias during anaesthesia. Br. J. Anaesth. 1970; 42: 1005
- Husaini M. H., Kvasnicka J., Rydén L., Holmberg S. Action of verapamil in sinus, no atrioventricular and intraventricular conduction. Br. Heart J. 1973; 35: 734
- Heng M. K., Singh B. N., Roche A. H. G., Norris R. M., Mercer C. J. Effects of intravenous verapamil on cardiac arrhythmias and on the electrocardiogram. Am. Heart J. 1975; 90: 487
- Rosen M. R., Wit A. L., Hoffman B. F. Electrophysiology and pharmacology of cardiac arrhythmias, VI. Cardiac effects of verapamil. Am. Heart J. 1975; 89: 665
- Hordof A. J., Edie R., Malm J. R., Hoffman B. F., Rosen M. R. Electrophysiologic properties and response to pharmacologic agents of fibers from diseased human heart. Circulation 1976; 54: 774
- Sandler G., Clayton G. A., Thornicraff S. G. Clinical evaluation of verapamil in angina pectoris. Br. Med. J. 1968; 3: 224
- Golenhofen K., Lammel E. Selective suppression of some components of spontaneous activity in various types of smooth muscles by iproveratril (verapamil). Pfleugers Arch. 1972; 331: 233
- Haeusler G. Differential effect of verapamil in excitation-contraction coupling in smooth muscle and on excitation-secretion coupling in adrenergic nerve terminals. J. Pharmacol. Exp. Ther. 1972; 180: 672
- Gushi N., Mateis Filho D.A., Magaldi J. B. Uso clinico do verapamil nas crises hipertensivas. Arq. Bras. Cardiol. 1976; 29: 67
- Davis G., Somers G., Van Obberghen E., Malaisse W. J. Calcium antagonists and islet function. I. Inhibition of insulin release by verapamil. Diabetes 1975; 24: 547
- Nayler W. G., McInnes I., Swann J. B., Price J. M., Carson V., Race D., Lowe T. E. Some effects of iproveratril (isoptin) on the cardiovascular system. J. Pharmacol. Exp. Ther. 1968; 161: 247
- Fleckenstein A., Kammermeier H., Doring H. J., Freund H. J. Zum Virkunsgsmechanismus neuartiger koronardilatotoren mit gleischzeitig sauerstoff-einspareden myokard-effecten, prenylamin un iproveratril. Z. Kreislaufforsch. 1967; 56: 716
- Shigenobu K., Schneider J. A., Sperelakis N. Verapamil blockade of slow Na+ and Ca++ responses in myocardial cells. J. Pharmacol. Exp. Ther. 1974; 190: 280
- Akhtar M., Damato A. N. Clinical uses of His bundle electrocardiography. I. Am. Heart J. 1976; 91: 520